Pharma's Supercomputer Arms Race Is Rewriting Drug Discovery

The Big Idea

Something peculiar is happening in the pharmaceutical industry, and it involves a lot of very expensive hardware. For the third time in nine months, a major drugmaker has announced plans to build what it calls the most powerful AI supercomputer in the life sciences industry. This time, Bristol Myers Squibb is making the claim — and they're not being subtle about it. Their new vice president of research business insights and technology, Erin Davis, has even given it a nickname:...